- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Steroid-refractory Gastrointestinal Acute Graft Versus Host Disease in United States
Total 617 results
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoAstex Pharmaceuticals, Inc.CompletedGraft vs Host DiseaseUnited States
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseUnited States
-
John LevineRecruitingAdverse Effects | Acute Graft vs Host Disease | Allogeneic Bone Marrow TransplantationUnited States, Canada
-
University Hospital BirminghamUnknownGraft Versus Host Disease | Nonneoplastic ConditionUnited Kingdom
-
M.D. Anderson Cancer CenterIncyte CorporationActive, not recruitingHematologic and Lymphocytic DisorderUnited States
-
University of Michigan Rogel Cancer CenterCompletedHematologic Malignancies | Graft-Versus-Host Disease | RelapseUnited States
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Moderate-Severe Chronic Graft Versus Host DiseaseUnited States
-
Boston Children's HospitalEnrolling by invitationInflammatory Bowel Diseases | Functional Gastrointestinal Disorders | Graft Vs Host DiseaseUnited States
-
OcugenTerminatedGraft vs Host Disease | Ocular Surface Disease | Graft Versus Host Disease | Ocular Graft vs Host Disease | Ophthalmic Solutions | oGVHD | Brimonidine Tartrate | Lubricant Eye DropsUnited States
-
National Cancer Institute (NCI)National Institute of Neurological Disorders and Stroke (NINDS)Recruiting
-
AmgenTerminatedChronic Graft Versus Host Disease cGVHDUnited States, Japan, France, Belgium
-
University of MiamiRecruitingQuality of Life | Coping Skills | Graft Vs Host Disease | Stem Cell Transplant ComplicationsUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedAllogeneic Hematopoietic Stem Cell TransplantationUnited States, Belgium, Sweden, France, Norway
-
Kadmon, a Sanofi CompanyTerminatedEfficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapyChronic Graft-versus-host-diseaseUnited States
-
Dana-Farber Cancer InstituteCompletedChronic Versus Graft Host DiseaseUnited States
-
Northside Hospital, Inc.SanofiRecruitingChronic Graft Versus Host DiseaseUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
National Cancer Institute (NCI)Recruiting
-
National Institute of Dental and Craniofacial Research...RecruitingGraft Versus Host DiseaseUnited States
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
Ronald PaquetteRecruiting
-
Cambium Medical Technologies LLCUniversity of Michigan; Duke University; Oregon Health and Science University; Stanford... and other collaboratorsCompletedDry Eye | Graft-versus-host-disease | Ocular DiscomfortUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedGraft Versus Host DiseaseUnited States
-
Stefanie Sarantopoulos, MD, PhD.National Institutes of Health (NIH); Incyte Corporation; Rigel PharmaceuticalsNot yet recruitingChronic Graft Versus Host DiseaseUnited States
-
Regimmune CorporationCompletedGraft Versus Host DiseaseUnited States
-
University of FloridaAmerican Cancer Society, Inc.CompletedHematopoietic Stem Cell Transplantation | Graft vs Host Disease | Graft Versus Host Disease | Peripheral Blood Stem Cell TransplantationUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingGraft vs Host Disease | Graft Rejection | Graft-versus-leukemiaUnited States
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedAcute Leukemia | MyelodysplasiaUnited States
-
Incyte CorporationTerminatedChronic Graft-versus-host DiseaseUnited States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
National Cancer Institute (NCI)CompletedChronic Graft Versus Host Disease | Stem Cell Transplant | Bronchiolitis Obliterans | Leukotriene | MontelukastUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedGraft vs Host Disease | Hematologic NeoplasmUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...CompletedHematologic Malignancies | Graft Versus Host DiseaseUnited States
-
Washington University School of MedicineCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Multiple Myeloma | Leukemia, Myelogenous, ChronicUnited States
-
Guenther KoehneSuspendedMyelodysplastic Syndromes | Graft Vs Host Disease | Graft-versus-host-diseaseUnited States
-
Kadmon, a Sanofi CompanyRecruitingChronic Graft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterSanofiRecruitingChronic Graft Versus Host DiseaseUnited States
-
National Cancer Institute (NCI)RecruitingHematopoietic Stem Cell Transplantation | Peripheral Blood Stem Cell TransplantationUnited States
-
Mayo ClinicNot yet recruitingChronic Graft Versus Host Disease | Hematopoietic and Lymphatic System NeoplasmUnited States
-
University of British ColumbiaActive, not recruitingChronic Graft vs Host DiseaseCanada, United States, Austria
-
Pavan Reddy, MDCompletedGraft vs Host Disease | Hematologic MalignanciesUnited States
-
Dana-Farber Cancer InstituteTerminated
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prometheus Laboratories; Miltenyi Biomedicine...Active, not recruitingChronic Graft Versus Host Disease | Chronic GVHD | Complications of Organ Transplant Stem CellsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Terminated
-
Fred Hutchinson Cancer CenterPfizerTerminatedChronic Graft Versus Host Disease | FasciitisUnited States
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Graft vs. Host Disease (GvHD)United States, Canada